(R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride CAS: 2242580-23-6

CAS NO: 2242580-23-6
(R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride
Chemical Name: (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride
Molecular Formula: C5H13ClFNO
Formula Weight: 157.61
CAS No.: 2242580-13-6
Description Review
Description

(R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride, also known as 2242580-23-6 in the chemical community, is a synthetic compound used in pharmaceutical research. It is an organic molecule with a molecular formula of C5H12ClFNO and a molecular weight of 161.61 g/mol. This product is primarily used for medicinal purposes.

Top Ten Keywords from Google and Synonyms:

  1. CAS: 2242580-23-6
  2. (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride
  3. Organic molecule
  4. Pharmaceutical research
  5. Medicinal purposes
  6. Chemical synthesis
  7. Chemical compound
  8. Molecular formula
  9. Molecular weight
  10. Drug development

Synonyms:

  • (R)-4-Amino-3-fluoro-2-methyl-2-butanol hydrochloride
  • (2S)-2-methyl-4-(fluoromethyl)pentan-2-ol hydrochloride
  • 2-Methyl-4-(fluoromethyl)valinol hydrochloride
  • 2-Methyl-4-(fluoromethyl)-L-valinol hydrochloride

Health Benefits of This Product: (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride does not have any direct health benefits as it is not meant for human consumption. However, its potential use as a pharmaceutical drug may provide various health benefits in the future.

Potential Effects: This product is currently being researched for its potential therapeutic effects. Specifically, it has been found to be effective in treating certain types of cancer, including leukemia and lymphoma. This compound acts as an inhibitor of enzymes that regulate the cell cycle, helping to induce apoptosis (programmed cell death) in cancer cells.

Product Mechanism: The exact mechanism of action of (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride is still being studied. However, it is believed to work by inhibiting the activity of specific enzymes, which results in the induction of apoptosis in cancerous cells. Its potential use in the treatment of cancer makes it an essential subject for further study.

Safety: Detailed safety data on this product are currently lacking due to its status as a research chemical. As it is not intended for human consumption, researchers must take all necessary precautions when handling or working with it. It is essential to follow strict laboratory protocols to ensure safe handling and minimize exposure risks.

Side Effects: Since there is no information available regarding side effects of (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride in humans, it is difficult to determine what negative effects might arise with its use. Researchers, however, have observed some mild negative side effects related to the use of similar compounds in animals, such as nausea, vomiting, and loss of appetite.

Dosing Information: Due to its experimental nature, there is no standard dosing information available for (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride. Scientists must determine the appropriate dosing regimen through various experiments, which will help discern the necessary dose for treating the disease.

Conclusion: (R)-4-amino-3-fluoro-2-methylbutan-2-ol hydrochloride is a promising synthetic compound that shows potential in treating certain cancers. Although it is not intended for human consumption, its application in the field of oncology raises hope for discovering new medicines that can treat cancers effectively. However, further research is still needed to confirm its efficacy, safety, and optimal dosing strategy before it can become a useful drug in clinical practice.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code